Claire M.Goulding


Sydney + 61.2.8272.0513

Claire Goulding is a commercial dispute resolution lawyer. She has worked on complex disputes in a range of jurisdictions, including the Federal Court of Australia and various state supreme courts, involving high-value contractual, joint ventures, alleged breaches of directors' duties, and trade practices matters. She also has experience in alternative dispute resolution processes.

Recently, Claire has focused on the construction and infrastructure sectors involving disputes with major mining and infrastructure projects across Australia, including a dispute against a large multinational regarding a mining project in Western Australia, a dispute involving extension of time and liquidated damages claims in relation to a mining project in Central Western New South Wales, and successful adjudication applications for the Gladstone LNG Project in Queensland and a nuclear medicine facility in New South Wales.

Claire also has worked on commercial disputes for various other clients, including acting for a global technology company in an action against a third-party service provider and advising a foreign multinational on a significant joint venture. In addition, she has experience with an application before the Federal Court of Australia for approval of a scheme of arrangement (under Australian company law) and on the litigation aspects of a due diligence process undertaken in relation to the acquisition of a coal mine in Central Queensland.

Prior to joining Jones Day, Claire volunteered at the Australian Centre for Disability Law.


  • Coronado Coal acquires Curragh coal mine in central Queensland, Australia, from Wesfarmers Limited for A$700 million (US$539 million)Jones Day advised Coronado Coal LLC in the acquisition of the Curragh coal mine in central Queensland, Australia, from Wesfarmers Limited for A$700 million (US$530 million).
  • Pepper Group acquired by KKR in A$675.9 million scheme of arrangementJones Day advised Pepper Group Limited ("Pepper") on the acquisition of a controlling interest in Pepper by way of scheme of arrangement by an affiliate of KKR, a leading global investment firm.
  • Cardinal Health acquires leading patient product portfolio from Medtronic for $6.1 billionJones Day advised Cardinal Health on the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.